Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MKL
MKL logo

MKL Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Markel Group Inc (MKL) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1844.000
1 Day change
-0.11%
52 Week Range
2207.590
Analysis Updated At
2026/05/15
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Markel Group is not a strong buy right now for a beginner long-term investor, even with $50,000-$100,000 available. The stock has some constructive signs, but the current setup is mixed: technical momentum is improving, options sentiment is favorable, and recent insider/congress activity leans positive, yet Wall Street coverage remains only Hold/Neutral and the longer-term moving-average structure is still bearish. Since the user wants an immediate, direct answer and is not waiting for a perfect entry, my call is hold rather than buy.

Technical Analysis

MKL is trading pre-market at 1846.01, very close to resistance at 1844.331 and below the next resistance at 1869.747. MACD is positive and expanding, which supports near-term upside momentum, while RSI_6 at 59.438 is neutral and not overextended. However, the moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, indicating the broader trend has not fully turned bullish yet. The stock trend model suggests modest near-term gains, but the technical picture is still more supportive of a cautious hold than an aggressive buy.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Options sentiment is constructive. The open interest put-call ratio of 0.45 is bullish, showing more call positioning than puts on an open-interest basis. The volume put-call ratio of 4.0 shows heavier put trading today, which can reflect hedging or short-term caution, but total options activity is light at only 10 contracts versus average activity, so this is not a strong conviction signal. Overall, options data leans mildly bullish but not decisively.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
3

Positive Catalysts

  • ["Recent product expansion in ProSolutions, including new professional liability insurance options for content creators and media professionals.", "A new blended ProSolutions form that simplifies coverage and may improve sales efficiency.", "Director Diane Leopold purchased 150 shares worth about $268,720, a positive insider signal.", "Congress trading data shows 1 recent purchase and no sales, suggesting favorable institutional/political sentiment.", "MACD is positive and expanding, indicating improving near-term momentum."]

Neutral/Negative Catalysts

  • ["Truist cut its price target to $1,950 from $2,100 and kept a Hold rating after below-consensus Q1 results.", "Brean Capital is only Neutral and said next-12-month performance is less certain.", "Bearish moving-average structure remains in place, with SMA_200 above shorter averages.", "Options volume put-call ratio is elevated at 4.0, implying notable short-term caution or hedging.", "No strong proprietary buy signal from AI Stock Picker or SwingMax."]

Financial Performance

No quarterly financial snapshot was available because the provided financial data produced an error. Based on the analyst notes, the latest quarter appears to have underperformed expectations, since Truist specifically cited below-consensus Q1 results and reduced assumptions for non-insurance operations. The missing financial snapshot prevents a precise growth assessment, but the available commentary suggests the latest quarter season was weaker than expected rather than a clear acceleration.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is cautious and has softened recently. Truist lowered its price target to $1,950 from $2,100 and kept a Hold rating, citing weaker Q1 results and lower assumptions for non-insurance contributions. Brean Capital resumed coverage with a Neutral rating and a $2,100 target, saying the stock may outperform over time but the next 12 months are uncertain. Wall Street pros are essentially split between mild optimism over the long term and hesitation on near-term upside, so the overall view is neutral rather than bullish.

Wall Street analysts forecast MKL stock price to rise
Analyst Rating
0
Wall Street analysts forecast MKL stock price to rise
Buy
Hold
Sell
0
Current: 1846.010
sliders
Low
0
Averages
0
High
0
0
Current: 1846.010
sliders
Low
0
Averages
0
High
0
Truist
Mark Hughes
Hold
downgrade
AI Analysis
2026-04-30
Reason
Truist
Mark Hughes
Price Target
AI Analysis
2026-04-30
downgrade
Hold
Reason
Truist analyst Mark Hughes lowered the firm's price target on Markel to $1,950 from $2,100 and keeps a Hold rating on the shares. The firm cites the company's below-consensus Q1 results as well as a lower assumed contribution from its non-insurance operations, also reducing its price target on multiple compression across the P&C carrier group, the analyst tells investors in a research note.
Brean Capital
Neutral
maintain
$2,100
2026-03-24
Reason
Brean Capital
Price Target
$2,100
2026-03-24
maintain
Neutral
Reason
Brean Capital resumed coverage of Markel with a Neutral rating and $2,100 price target. The firm believes shares will outperform the S&P 500 over time, but performance in the next 12 months is "less certain" given the numerous changes management has made to shore up profitability in Markel Insurance, the analyst tells investors.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for MKL
Unlock Now

People Also Watch